Table 2.
Univariate and Multivariate Analyses of Factors Associated with Transaminase and GGT Normalization by Lipid-Lowering Agents
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | |
| Female | 1.01 (0.55–1.85) | 0.985 | - | - |
| Age, years | 1.01 (0.99–1.03) | 0.479 | - | - |
| Baseline BMI ≥23kg/m2 | 0.74 (0.36–1.53) | 0.419 | - | - |
| Baseline TC ≥5.2mmol/L | 1.26 (0.62–2.53) | 0.523 | - | - |
| Baseline TG ≥1.7mmol/L | 1.25 (0.60–2.51) | 0.525 | - | - |
| Baseline LDL-c ≥3.4mmol/L | 1.23 (0.64–2.36) | 0.538 | - | - |
| Weight loss (%) | 1.81 (1.03–3.12) | 0.039 | 1.60 (0.87–2.95) | 0.132 |
| TC decreased over 50% | 1.84 (0.98–3.40) | 0.049 | 1.28 (0.61–2.65) | 0.514 |
| TG decreased over 50% | 2.08 (1.14–3.82) | 0.018 | 2.07 (1.12–3.84) | 0.020 |
| LDL-c decreased over 50% | 1.85 (1.03–3.32) | 0.040 | 1.64 (0.83–3.21) | 0.154 |
Abbreviations: GGT, gamma glutamyltranspeptidase; BMI, body mass index; TC, total cholesterol; TG, triglyceride; LDL-c, low-density lipoprotein cholesterol.